These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16583267)

  • 1. Elevation in plasma Abeta42 in geriatric depression: a pilot study.
    Pomara N; Doraiswamy PM; Willoughby LM; Roth AE; Mulsant BH; Sidtis JJ; Mehta PD; Reynolds CF; Pollock BG
    Neurochem Res; 2006 Mar; 31(3):341-9. PubMed ID: 16583267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble amyloid-β levels and late-life depression.
    Osorio RS; Gumb T; Pomara N
    Curr Pharm Des; 2014; 20(15):2547-54. PubMed ID: 23859552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression.
    Pomara N; Bruno D; Osorio RS; Reichert C; Nierenberg J; Sarreal AS; Hernando RT; Marmar CR; Wisniewski T; Zetterberg H; Blennow K
    Neuroreport; 2016 Sep; 27(14):1068-71. PubMed ID: 27508979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of amyloid-β protein may be affected in depression.
    Baba H; Nakano Y; Maeshima H; Satomura E; Kita Y; Suzuki T; Arai H
    J Clin Psychiatry; 2012 Jan; 73(1):115-20. PubMed ID: 22152118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study.
    Pomara N; Bruno D; Plaska CR; Ramos-Cejudo J; Osorio RS; Pillai A; Imbimbo BP; Zetterberg H; Blennow K
    Transl Psychiatry; 2022 Jul; 12(1):301. PubMed ID: 35902554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of elderly depression: increased risk of Alzheimer's disease and Aβ protein metabolism.
    Namekawa Y; Baba H; Maeshima H; Nakano Y; Satomura E; Takebayashi N; Nomoto H; Suzuki T; Arai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():203-8. PubMed ID: 23276885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Aβ analysis using magnetically-labeled immunoassays and PET
    Wu KY; Hsiao IT; Chen CH; Liu CY; Hsu JL; Huang SY; Yen TC; Lin KJ
    Sci Rep; 2018 Feb; 8(1):2739. PubMed ID: 29426824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amyloid beta-42 independently predicts both late-onset depression and Alzheimer disease.
    Blasko I; Kemmler G; Jungwirth S; Wichart I; Krampla W; Weissgram S; Jellinger K; Tragl KH; Fischer P
    Am J Geriatr Psychiatry; 2010 Nov; 18(11):973-82. PubMed ID: 20808106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid beta protein in young and elderly depression: a pilot study.
    Kita Y; Baba H; Maeshima H; Nakano Y; Suzuki T; Arai H
    Psychogeriatrics; 2009 Dec; 9(4):180-5. PubMed ID: 20377819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression.
    Yamazaki C; Tamaoki T; Nunomura A; Tamai K; Yasuda K; Motohashi N
    J Alzheimers Dis; 2017; 58(2):349-354. PubMed ID: 28453490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease.
    Sun X; Mwamburi DM; Bungay K; Prasad J; Yee J; Lin YM; Liu TC; Summergrad P; Folstein M; Qiu WQ
    Biol Psychiatry; 2007 Dec; 62(12):1413-7. PubMed ID: 17544381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of Interleukin 18 but not amyloid-β or Tau are elevated in female depressive patients.
    Liu FR; Yang LY; Zheng HF; Zhou Y; Chen BB; Xu H; Zhang YW; Shen DY
    Compr Psychiatry; 2020 Feb; 97():152159. PubMed ID: 31931428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid may influence amyloid β metabolism in patients with depression.
    Ishijima S; Baba H; Maeshima H; Shimano T; Inoue M; Suzuki T; Arai H
    Psychiatry Res; 2018 Jan; 259():191-196. PubMed ID: 29073556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amyloid-β levels in drug-resistant bipolar depressed patients receiving electroconvulsive therapy.
    Piccinni A; Veltri A; Vizzaccaro C; Catena Dell'Osso M; Medda P; Domenici L; Vanelli F; Cecchini M; Franceschini C; Conversano C; Marazziti D; Dell'Osso L
    Neuropsychobiology; 2013; 67(4):185-91. PubMed ID: 23635805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.
    Qiu WQ; Sun X; Selkoe DJ; Mwamburi DM; Huang T; Bhadela R; Bergethon P; Scott TM; Summergrad P; Wang L; Rosenberg I; Folstein M
    Int J Geriatr Psychiatry; 2007 Jun; 22(6):536-42. PubMed ID: 17096467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.